Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC)
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-07-01
|
| Series: | European Urology Open Science |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320338428 |
| _version_ | 1819055953605033984 |
|---|---|
| author | L.C.V. Thomsen A. Honoré B. Almås L.A.R. Reisæter K. Førde E.K. Kristoffersen S.H. Kaada G.K. Melve S.I. Helle G. Kvalheim W. Azeem J.R. Olsen O.J. Halvorsen L.A. Akslen D. Bahn K. Pantel S. Riethdorf H. Ragde B.T. Gjertsen A.M. Øyan K.H. Kalland C. Beisland |
| author_facet | L.C.V. Thomsen A. Honoré B. Almås L.A.R. Reisæter K. Førde E.K. Kristoffersen S.H. Kaada G.K. Melve S.I. Helle G. Kvalheim W. Azeem J.R. Olsen O.J. Halvorsen L.A. Akslen D. Bahn K. Pantel S. Riethdorf H. Ragde B.T. Gjertsen A.M. Øyan K.H. Kalland C. Beisland |
| author_sort | L.C.V. Thomsen |
| collection | DOAJ |
| first_indexed | 2024-12-21T13:15:43Z |
| format | Article |
| id | doaj.art-115ffecc68e840f895a0f6060b80f904 |
| institution | Directory Open Access Journal |
| issn | 2666-1683 |
| language | English |
| last_indexed | 2024-12-21T13:15:43Z |
| publishDate | 2020-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | European Urology Open Science |
| spelling | doaj.art-115ffecc68e840f895a0f6060b80f9042022-12-21T19:02:44ZengElsevierEuropean Urology Open Science2666-16832020-07-0119e1844e1845Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC)L.C.V. ThomsenA. HonoréB. AlmåsL.A.R. ReisæterK. FørdeE.K. KristoffersenS.H. KaadaG.K. MelveS.I. HelleG. KvalheimW. AzeemJ.R. OlsenO.J. HalvorsenL.A. AkslenD. BahnK. PantelS. RiethdorfH. RagdeB.T. GjertsenA.M. ØyanK.H. KallandC. Beislandhttp://www.sciencedirect.com/science/article/pii/S2666168320338428 |
| spellingShingle | L.C.V. Thomsen A. Honoré B. Almås L.A.R. Reisæter K. Førde E.K. Kristoffersen S.H. Kaada G.K. Melve S.I. Helle G. Kvalheim W. Azeem J.R. Olsen O.J. Halvorsen L.A. Akslen D. Bahn K. Pantel S. Riethdorf H. Ragde B.T. Gjertsen A.M. Øyan K.H. Kalland C. Beisland Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC) European Urology Open Science |
| title | Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC) |
| title_full | Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC) |
| title_fullStr | Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC) |
| title_full_unstemmed | Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC) |
| title_short | Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC) |
| title_sort | safety and efficacy of dendritic cell dc based cryoimmunotherapy cryoit combined with checkpoint inhibition in a prospective non randomized phase i trial of metastatic castration resistant prostate cancer mcrpc |
| url | http://www.sciencedirect.com/science/article/pii/S2666168320338428 |
| work_keys_str_mv | AT lcvthomsen safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT ahonore safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT balmas safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT larreisæter safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT kførde safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT ekkristoffersen safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT shkaada safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT gkmelve safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT sihelle safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT gkvalheim safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT wazeem safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT jrolsen safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT ojhalvorsen safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT laakslen safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT dbahn safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT kpantel safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT sriethdorf safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT hragde safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT btgjertsen safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT amøyan safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT khkalland safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc AT cbeisland safetyandefficacyofdendriticcelldcbasedcryoimmunotherapycryoitcombinedwithcheckpointinhibitioninaprospectivenonrandomizedphaseitrialofmetastaticcastrationresistantprostatecancermcrpc |